When PSMD14 is inhibited genetically or pharmacologically, IMPDH2 stability diminishes, causing impaired nucleotide metabolism, mitochondrial dysfunction, increased DNA damage signaling, and reduced tumor malignancy. Here, PSMD14 is linked to neoplasm.